Neurones SA (NRO):企業の財務・戦略的SWOT分析

◆英語タイトル:Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1035
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Neurones SA (NRO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Neurones SA (Neurones) provides management consulting and digital services. The company offers digital transformation, infrastructure services, application services, consulting and outsourcing. Under digital transformation it offers innovation/ new services, analytics/big data, internet of things, develops-agile/cloud/ security and mobility. Under infrastructure services the company offers server, system and networks, user support, IT service management, outsourcing in cloud computing/ security and IT governance. Neurones serves banking and insurance, services and consumer goods, public sector, energy, utilities, healthcare, public works and civil engineering, technology, media, and telecommunications sectors. The company operates through a network of service, support, hosting, and application maintenance centers. It has business presence in Germany, Belgium, Switzerland, Romania, Tunisia, India, France and Singapore. Neurones is headquartered in Paris, France.

Neurones SA Key Recent Developments

Aug 01,2019: NEURONES: + 5.3% organic growth in the 1st half of 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Neurones SA – Key Facts
Neurones SA – Key Employees
Neurones SA – Key Employee Biographies
Neurones SA – Major Products and Services
Neurones SA – History
Neurones SA – Company Statement
Neurones SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Neurones SA – Business Description
Business Segment: Application Services
Overview
Performance
Business Segment: Consulting
Overview
Performance
Business Segment: Infrastructure Services
Overview
Performance
Neurones SA – Corporate Strategy
Neurones SA – SWOT Analysis
SWOT Analysis – Overview
Neurones SA – Strengths
Neurones SA – Weaknesses
Neurones SA – Opportunities
Neurones SA – Threats
Neurones SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Aug 01, 2019: NEURONES: + 5.3% organic growth in the 1st half of 2019
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Neurones SA, Key Facts
Neurones SA, Key Employees
Neurones SA, Key Employee Biographies
Neurones SA, Major Products and Services
Neurones SA, History
Neurones SA, Subsidiaries
Neurones SA, Key Competitors
Neurones SA, Ratios based on current share price
Neurones SA, Annual Ratios
Neurones SA, Annual Ratios (Cont...1)
Neurones SA, Annual Ratios (Cont...2)
Neurones SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Neurones SA, Performance Chart (2014 - 2018)
Neurones SA, Ratio Charts

★海外企業調査レポート[Neurones SA (NRO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Helios and Matheson Analytics Inc (HMNY):企業の財務・戦略的SWOT分析
    Summary Helios and Matheson Analytics Inc (Helios and Matheson) is a big data company. It offers IT infrastructure, social data aggregation, cognitive computing, map-tech innovation, application development, pattern discovery solutions. The company's analytic solutions find application across a broa …
  • M.C. Dean, Inc.:戦略・SWOT・企業財務分析
    M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report Summary M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Massachusetts General Hospital:企業のM&A・事業提携・投資動向
    Massachusetts General Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Massachusetts General Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Refresco Gerber B.V.:企業の戦略・SWOT・財務情報
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clinical Laserthermia Systems AB (CLS B):企業の財務・戦略的SWOT分析
    Clinical Laserthermia Systems AB (CLS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • American Bio Medica Corp (ABMC):企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, Rapid One, and Rapid Drug Screen, among others. It offers OralStat used for the detection of drugs in oral fluids. ABMC also pro …
  • Nipro Corp (8086):企業の財務・戦略的SWOT分析
    Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • 908 Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary 908 Devices Inc (908 Devices) is a manufacturer of handheld chemical detection tools, tiny footprint analyzers and fast separation devices. The company’s product portfolio includes MX908, a second-generation tool that leverages high-pressure mass spectrometry (HPMS); M908 focuses on priority …
  • MI Bioresearch Inc-製薬・医療分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dai-ichi Life Holdings, Inc.:企業の戦略・SWOT・財務分析
    Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The National Gas Company of Trinidad and Tobago Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary The National Gas Company of Trinidad and Tobago Ltd (NGC) is a state-owned natural gas company that purchases, compresses, transmits, distributes and sells natural gas to industrial and commercial customers. The company also has investments in the downstream and upstream segments of the natu …
  • Abivax SA (ABVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • Vicinity Centres Re Ltd:企業の戦略・SWOT・財務分析
    Vicinity Centres Re Ltd - Strategy, SWOT and Corporate Finance Report Summary Vicinity Centres Re Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PNM Resources, Inc. (PNM):電力:M&Aディール及び事業提携情報
    Summary PNM Resources, Inc. (PNMR) is an energy holding company. Through its utilities PNM and TNMP, the company generates, transmits, and distributes electricity; and transports natural gas. It produces electricity from coal, natural gas, nuclear, solar, wind, and geothermal sources. Through long-t …
  • PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報
    Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of …
  • Roper Technologies Inc (ROP):医療機器:M&Aディール及び事業提携情報
    Summary Roper Technologies Inc (Roper), formerly Roper Industries Inc, is a diversified technology company. It designs and develops software, and engineered products and solutions. It offers both software-as-a-service and licensed to customers. The company serves healthcare, water, food, transportat …
  • Wellcome Trust Sanger Institute:医療機器:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Recipharm AB (RECI B):企業の財務・戦略的SWOT分析
    Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆